Lv4
462 积分 2021-07-20 加入
TPPP/p25 amyloid seeding activity as a specific biomarker for multiple system atrophy
1天前
待确认
Bulumtatug Fuvedotin (BFv, 9MW2821), a next-generation Nectin-4 targeting antibody–drug conjugate, in patients with advanced solid tumors: a first-in-human, open-label, multicenter, phase I/II study
1个月前
已完结
The present and future of bispecific antibodies for cancer therapy
2个月前
已完结
Multispecific T-cell engagers attract cancer drug developers
2个月前
已完结
Unlocking the potential of T cell engagers in solid tumors
2个月前
已完结
P-glycoprotein (P-gp)-driven cancer drug resistance: biological profile, non-coding RNAs, drugs and nanomodulators
5个月前
已完结
The Pathophysiology and Management of Pathologic Scarring—a Contemporary Review
8个月前
已完结
[National expert consensus on early management of scars (2020 version)]
8个月前
已完结
IL-11/IL-11R signal inhibition by 9MW3811 remodels immune tumor microenvironment and enhances anti-tumor efficacy of PD-1 blockade
1年前
已完结
皖公网安备34019202002308
